p16 promoter hypermethylation: A useful serum marker for early detection of gastric cancer

Abbaszadegan, Mohammad Reza; Moaven, Omeed; Sima, Hamid Reza; Ghafarzadegan, Kamran; A'rabi, Azadeh; Forghani, Mohammad Naser; Raziee, Hamid Reza; Mashhadinejad, Ali; Jafarzadeh, Mostafa; Esmaili-Shandiz, Ehsan; Dadkhah, Ezzat; Shingo Tsuji
April 2008
World Journal of Gastroenterology;4/7/2008, Vol. 14 Issue 13, p2055
Academic Journal
AIM: To determine p16 promoter hypermethylation in gastric tumoral tissue and serum samples, its impact on p16-protein expression, and correlation with clinical and histological features. METHODS: Samples were obtained from 52 histologically confirmed cases of gastric adenocarcinoma. Gastric tissue and serum of 50 age- and sex-matched individuals with normal gastroscopy and biopsy were obtained as control samples. Methylation-specific polymerase chain reaction (MSP) was used to evaluate methylation status of p16 promoter. p16-protein expression was analyzed by immunohistochemical staining on paraffin-embedded sections. RESULTS: Methylation was detected in 44.2% (23/52) of tumoral tissues. 60.9% of them were also methylated in serum, i.e., 26.9% of all patients (14/52). Methylation was not detected in tissue and sera of control samples. p16-protein expression was decreased in 61.5% of cases (32/52), and was significantly associated with promoter hypermethylation (P < 0.001). Methylation was significantly more frequent in higher pathological grades (P < 0.05). Methylation was not associated with other clinicopathological features and environmental factors including H pylori infection and smoking. CONCLUSION: p16 promoter hypermethylation is an important event in gastric carcinogenesis. It is the principle mechanism of p16 gene silencing. It is related to malignant tumor behavior. Detection of DNA methylation in serum may be a biomarker for early detection of gastric cancer.


Related Articles

  • Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer. Lin Wang; Li Xie; Jun Wang; Jie Shen; Baorui Liu // BMC Gastroenterology;2013, Vol. 13 Issue 1, p1 

    Background At present, no study has compared the correlation between SULF2, WRN promoter methylation and clinicopathological parameters of patients with gastric cancer and the sensitivity to irinotecan (CPT-11). Methods We collected 102 fresh tumor tissues from pathologically diagnosed gastric...

  • Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients. Song, Jianning; Bai, Zhigang; Han, Wei; Zhang, Jun; Meng, Hua; Bi, Jintao; Ma, Xuemei; Han, Shiwei; Zhang, Zhongtao // Digestive Diseases & Sciences;Apr2012, Vol. 57 Issue 4, p897 

    Background: Circulating microRNA expression profiles may be promising biomarkers for diagnosis and assessment of the prognosis of cancer patients. Quantitative polymerase chain reaction (qPCR) is a sensitive technique for estimating expression levels of circulating microRNAs. However, there is...

  • Prohibitin: a potential biomarker for tissue-based detection of gastric cancer. Xiandong Kang; Long Zhang; Jian Sun; Zhenhua Ni; Yanchun Ma; Xiaobo Chen; Xia Sheng; Teng Chen // Journal of Gastroenterology;2008, Vol. 43 Issue 8, p618 

    Prohibitin (PHB) was found to be overexpressed in breast cancer and thus is suggested as a biomarker in that disease. A few studies have investigated the PHB expression pattern in gastric cancer by two-dimensional gel electrophoresis. Uncertainties still existed on whether PHB expression could...

  • Clinicopathological Correlation and Prognostic Significance of Protein Kinase Cα Overexpression in Human Gastric Carcinoma. Lin, Shee-Chan; Chen, Wei-Yu; Lin, Kai-Yuan; Chen, Sheng-Hsuan; Chang, Chun-Chao; Lin, Sey-En; Fang, Chia-Lang // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Objectives: This study investigated the PKCα protein expression in gastric carcinoma, and correlated it with clinicopathological parameters. The prognostic significance of PKCα protein expression in gastric carcinoma was analyzed. Methods: Quantitative real-time PCR test was applied...

  • Quantitative Analysis and Diagnostic Significance of Methylated SLC19A3 DNA in the Plasma of Breast and Gastric Cancer Patients. Enders K. O. Ng; Candy P. H. Leung; Vivian Y. Shin; Chris L. P. Wong; Edmond S. K. Ma; Hong Chuan Jin; Kent-Man Chu; Ava Kwong // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: Previously, we have examined the methylation status of SLC19A3 (solute carrier family 19, member 3) promoter and found that SLC19A3 was epigenetically down-regulated in gastric cancer. Here, we aim to develop a new biomarker for cancer diagnosis using methylated SLC19A3 DNA in...

  • Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer. Chen, Lu; Su, Liping; Li, Jianfang; Zheng, Yanan; Yu, Beiqin; Yu, Yingyan; Yan, Min; Gu, Qinlong; Zhu, Zhenggang; Liu, Bingya // Disease Markers;2012, Vol. 32 Issue 3, p195 

    Most cases of gastric cancer (GC) are not diagnosed at early stage which can be curable, so it is necessary to identify effective biomarkers for its diagnosis and pre-warning. We have used methylated DNA immunoprecipitation (MeDIP) to identify genes that are frequently methylated in gastric...

  • DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA. HONGNA LU; SHILIANG HUANG; XIE ZHANG; DANPING WANG; XUESONG ZHANG; XIAOGANG YUAN; QIUBO ZHANG; ZHIGANG HUANG // Oncology Letters;2014, Vol. 8 Issue 4, p1751 

    Aberrantly methylated genes are increasingly being established as biomarkers for the detection of colorectal cancer (CRC). In the present study, the methylation levels of the secreted frizzled-related protein gene 2 (SFRP2), GATA binding protein 4/5 (GATA4/5), N-Myc downstream-regulated gene 4...

  • Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer. Ling, Zhi-Qiang; Lv, Ping; Lu, Xiao-Xiao; Yu, Jiang-Liu; Han, Jing; Ying, Li-Sha; Zhu, Xin; Zhu, Wang-Yu; Fang, Xian-Hua; Wang, Shi; Wu, Yi-Chen // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: Methylated DNA in fluids may be a suitable biomarker for cancer patients. XAF1 has been shown to be frequently down-regulated in human gastric cancer (GC). Here, we investigated if XAF1 methylation in GC could be a useful biomarker. Methods: Real-time RT-PCR was used to detect XAF1...

  • High-throughput detection of aberrant imprint methylation in the ovarian cancer by the bisulphite PCR-Luminex method.  // BMC Medical Genomics;2012, Vol. 5 Issue 1, p8 

    The article focuses on the study conducted to examine aberrant imprint methylation in the ovarian cancer using the bisulphite PCR-Luminex method. It mentions the aberrant DNA methylation results in the loss of heterozygosity (LOH) or loss of imprinting (LOI) during human carcinogenesis. It has...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics